Category: CAACB
-
CAACB Publishes on NGS
The Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB) collected historical data from 20 biopharmaceutical industry members on their experience with the in vivo adventitious…
-
BioPharm International publishes CBI Article on the Impact of SARS-CoV-2 on Biomanufacturing Operations
CBI has published a summary of the key takeaways from “The Impact of SARS-CoV-2 on Biomanufacturing Operations”, the first webinar in our ‘Biotechnology in the…
-
Nature Biotechnology publishes CAACB Article on Viral Contamination in Biologic Manufacture and Implications for Emerging Therapies
This report, made possible through the efforts of our consortium members, offers lessons learned to help prevent viruses from contaminating biopharmaceutical manufacturing processes. Read the…
-
Biotechnology in the Age of COVID-19 Webinar Series Launched, 4/19/2020
In response to the COVID-19 pandemic, the Center for Biomedical Innovation has hosted a series of collaborative webinars focused on how the biomanufacturing industry is…
-
The Bioprocessing Summit Interview with Paul Barone
Cambridge Healthtech Institute recently spoke with Dr. Paul Barone of Massachusetts Institute of Technology about Viral Safety and where the field and industry is headed…